Brad McMurray - Calumet Specialty Director Relations
| CLMT Stock | USD 13.38 0.16 1.21% |
Insider
Brad McMurray is Director Relations of Calumet Specialty Products
| Phone | 317-328-5660 |
| Web | https://calumet.com |
Calumet Specialty Management Efficiency
The company has return on total asset (ROA) of 0.0176 % which means that it generated a profit of $0.0176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.7222) %, meaning that it created substantial loss on money invested by shareholders. Calumet Specialty's management efficiency ratios could be used to measure how well Calumet Specialty manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| David Rockecharlie | Crescent Energy Co | 53 | |
| Hollie Lamb | Ring Energy | 49 | |
| Al Petrie | Ring Energy | N/A | |
| Andrs Ocampo | GeoPark | 47 | |
| Veronica Davila | GeoPark | N/A | |
| Emily Newport | Crescent Energy Co | N/A | |
| Beverly CPA | PrimeEnergy | 72 | |
| William III | Permian Resources | 37 | |
| Richard Harris | Ring Energy | 62 | |
| David Wolf | Gulfport Energy Operating | N/A | |
| Steven Packebush | PHX Minerals | 55 | |
| Angela Busch | Magnolia Oil Gas | 54 | |
| Stephanie Morris | PHX Minerals | N/A | |
| Ignacio Mazariegos | GeoPark | 34 | |
| Tyler Farquharson | Granite Ridge Resources | 43 | |
| Wade Caston | Granite Ridge Resources | N/A | |
| Witt Meloni | Granite Ridge Resources | N/A | |
| Diego Gully | GeoPark | N/A | |
| Jessica Antle | Gulfport Energy Operating | N/A | |
| Marcela Vaca | GeoPark | 57 | |
| Stacy Steimel | GeoPark | 60 | |
Management Performance
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0176 |
Calumet Specialty Leadership Team
Elected by the shareholders, the Calumet Specialty's board of directors comprises two types of representatives: Calumet Specialty inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Calumet. The board's role is to monitor Calumet Specialty's management team and ensure that shareholders' interests are well served. Calumet Specialty's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Calumet Specialty's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Hodges, Alpha IR | ||
| Louis Borgmann, CEO President | ||
| Marc Lawn, LLC GP | ||
| Vincent Donargo, Chief Officer | ||
| Brad McMurray, Director Relations | ||
| David Lunin, Executive CFO | ||
| Stephen Mawer, Independent Director of Calumet GP, LLC | ||
| Scott Obermeier, LLC GP | ||
| Gregory Morical, General VP | ||
| John Kompa, Director Relations | ||
| Bruce Fleming, Executive Vice President - Strategy and Growth of Calumet GP, LLC | ||
| Ryan Willman, LLC GP |
Calumet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Calumet Specialty a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0176 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 3.41 B | ||||
| Shares Outstanding | 86.21 M | ||||
| Shares Owned By Insiders | 20.99 % | ||||
| Shares Owned By Institutions | 42.42 % | ||||
| Number Of Shares Shorted | 8.57 M | ||||
| Price To Earning | 286.67 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.